STOCK TITAN

Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Twist Bioscience Corporation (NASDAQ: TWST) will release its fiscal 2023 Q1 financial results on February 3, 2023, before market opening. A conference call and live audio webcast will follow at 8:00 a.m. ET, aimed at discussing the results and providing business updates. The press release with details will be available on Twist's Investor Relations page.

Twist is a leader in synthetic biology and genomics, utilizing a cutting-edge DNA synthesis platform built on silicon technology, serving various sectors including healthcare and agriculture.

Positive
  • Twist Bioscience has developed a revolutionary DNA synthesis platform, indicating strong technological leadership.
  • The company is actively pursuing new opportunities in digital data storage and biologics drug discovery, signaling growth potential.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2023 first quarter ended December 31, 2022, before the opening of the market on Friday, February 3, 2023. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on the company’s business. The press release with the financial results will be accessible from the company’s website prior to the conference call through the Investor Relations section under the “Company” tab at www.twistbioscience.com.

The conference call will be webcast live through the Investor Relations section under the “Company” tab at www.twistbioscience.com. Those parties interested in participating via telephone must register on the Company’s Investor Relations website or by clicking here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast replay will be available for two weeks.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

For Twist Bioscience:

Angela Bitting

SVP, Corporate Affairs

925-202-6211

abitting@twistbioscience.com

Source: Twist Bioscience Corporation

FAQ

When will Twist Bioscience announce its financial results for Q1 2023?

Twist Bioscience will announce its financial results for Q1 2023 on February 3, 2023.

What time is the Twist Bioscience conference call on February 3, 2023?

The conference call for Twist Bioscience will be held at 8:00 a.m. Eastern Time on February 3, 2023.

Where can I find the financial results for Twist Bioscience?

The financial results for Twist Bioscience will be available on their Investor Relations page on their website.

What is the significance of Twist Bioscience's silicon DNA synthesis platform?

Twist Bioscience's silicon DNA synthesis platform represents a disruptive technology in synthetic biology, enhancing the manufacturing of synthetic DNA.

Twist Bioscience Corporation

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Stock Data

2.69B
58.31M
1.94%
110.12%
15.4%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States of America
SOUTH SAN FRANCISCO